These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30227748)

  • 21. [Rheumatic diseases in pregnancy].
    Märker-Hermann E; Bauer H; Gromnica-Ihle E
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.
    Elyoussfi S; Thomas BJ; Ciurtin C
    Rheumatol Int; 2016 May; 36(5):603-12. PubMed ID: 26892034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignancy and the Risks of Biologic Therapies: Current Status.
    Seror R; Mariette X
    Rheum Dis Clin North Am; 2017 Feb; 43(1):43-64. PubMed ID: 27890173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase
    Dernoncourt A; Liabeuf S; Bennis Y; Masmoudi K; Bodeau S; Laville S; Hurtel-Lemaire AS; Gras-Champel V; Batteux B
    BioDrugs; 2023 Jan; 37(1):73-87. PubMed ID: 36401769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis in children and adolescents with rheumatic diseases using biologic agents: an integrative review.
    Lima LM; Aurilio RB; Fonseca AR; Parente AAAI; Sant'Anna MFBP; Sant'Anna CC
    Rev Paul Pediatr; 2023; 42():e2022084. PubMed ID: 37436237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antirheumatic medications in pregnancy and breastfeeding.
    Birru Talabi M; Clowse MEB
    Curr Opin Rheumatol; 2020 May; 32(3):238-246. PubMed ID: 32205567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-α (TNF-α) targeted biologics and recently licensed TNF-α inhibitors: data from clinical trials and national registries.
    Cantini F; Niccoli L; Goletti D
    J Rheumatol Suppl; 2014 May; 91():56-64. PubMed ID: 24789001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of rheumatoid arthritis during pregnancy: present and future.
    Förger F; Villiger PM
    Expert Rev Clin Immunol; 2016 Sep; 12(9):937-44. PubMed ID: 27170517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of biologic agents for the management of rheumatic diseases during pregnancy.
    D'Gama JD; Bermas BL
    Curr Opin Rheumatol; 2024 May; 36(3):184-190. PubMed ID: 38456470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review.
    Chessa E; Piga M; Floris A; Congia M; Cangemi I; Mathieu A; Cauli A
    BioDrugs; 2021 Mar; 35(2):175-186. PubMed ID: 33595833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fetal safety profile of drugs used in the treatment of inflammatory rheumatic diseases].
    Falcão S; Mourão AF; Pimentão JB; Branco JC
    Acta Reumatol Port; 2007; 32(4):323-31. PubMed ID: 18159198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatologic Medication Use During Pregnancy.
    Peterson EA; Lynton J; Bernard A; Santillan MK; Bettendorf B
    Obstet Gynecol; 2020 May; 135(5):1161-1176. PubMed ID: 32282595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pregnancy in rheumatic patients treated with biologic drugs].
    Sentić M; Baresić M; Anić B; Bosnić D; Cerovec M; Mayer M; Smiljanić L; Cikes N
    Lijec Vjesn; 2010; 132(9-10):317-8. PubMed ID: 21261033
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.
    Iannone F; Ferraccioli G; Sinigaglia L; Favalli EG; Sarzi-Puttini P; Atzeni F; Gorla R; Bazzani C; Govoni M; Farina I; Gremese E; Carletto A; Giollo A; Galeazzi M; Foti R; Bianchino L; La Grasta L; Lapadula G
    Clin Rheumatol; 2018 Feb; 37(2):315-321. PubMed ID: 28980085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic therapy use and pregnancy outcomes in women with immune-mediated inflammatory rheumatic diseases.
    Brites L; Madeira N; Rodrigues J; Marona J; Martins N; Águeda A; Freitas R; Neto A; Capela S; Sequeira G; Ganhão S; Duarte C; Santiago M; Santos MJ
    Acta Reumatol Port; 2019; 44(4):266-272. PubMed ID: 32008032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with withdrawal of the anti-TNFα biologics in the treatment of rheumatic diseases: data from the Hong Kong Biologics Registry.
    Mok CC; Chan KY; Lee KL; Tam LS; Lee KW;
    Int J Rheum Dis; 2014 Dec; 17 Suppl 3():1-8. PubMed ID: 24382315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging drugs for psoriatic arthritis.
    Caso F; Del Puente A; Peluso R; Caso P; Girolimetto N; Del Puente A; Scarpa R; Costa L
    Expert Opin Emerg Drugs; 2016; 21(1):69-79. PubMed ID: 26807876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.
    Roux CH; Brocq O; Breuil V; Albert C; Euller-Ziegler L
    Rheumatology (Oxford); 2007 Apr; 46(4):695-8. PubMed ID: 17158212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence.
    Siddiqui MA
    Curr Opin Rheumatol; 2007 May; 19(3):308-13. PubMed ID: 17414961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.